Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi”), a licensed Canadian drug researcher and formulator specializing in controlled...
Can psychedelics assist in recovery from eating disorders? The findings are promising, but patients and doctors need to proceed with caution until there...
Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing...
European based biopharma MGC Pharmaceuticals has finalised a share consolidation and ~US$8 million funding as the company confidently looks towards the...
WA's government is re-energising its battery and critical minerals strategy, looking for feedback. Piedmont Lithium hits Q3 production profit. ... Read...
The firm says its existing cash will fund it through 2025. The post Compass Pathways Research, Clinical Trials Buoyed by Influx of New Funds appeared first...
Psyence Group Inc. (CSE:PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and...
Gold and uranium were the major ASX commodities in the winners list in October, while coal and lithium prices continued ... Read More The post Up,...
This morning we received interim results on Cybin’s Phase 2 trial using its CYB003 psilocybin compound for depression. And they did not disappoint. The...
Christian Antoni Montai Health has kept most of its business under wraps since emerging from stealth last December. But this week the startup hired its...